`Filed: January 11, 2017
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`MYLAN PHARMACEUTICALS INC.
`Petitioner
`
`v.
`
`ICOS CORPORATION
`Patent Owner
`______________________
`
`IPR2017-00323
`Patent No. 6,943,166
`______________________
`
`
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), Patent Owner, ICOS Corporation, hereby
`
`submits the following updated mandatory notices providing an update on the status
`
`of the Related Matters.
`
`I.
`
`ICOS CORPORATION’S MANDATORY NOTICES
`
`A. Real Parties-in-Interest
`
`In accordance with 37 C.F.R. § 42.8(b)(1), the real parties-in-interest include
`
`ICOS Corporation and Eli Lilly and Company.
`
`B. Related Matters
`
`The following district court actions filed by Eli Lilly and Company and
`
`ICOS Corporation, in the United States District Court for the Eastern District of
`
`Virginia, seek a judgment that the claims of U.S. Patent 6,943,166 are valid and
`
`infringed:
`
`• Eli Lilly & Co. v. Accord Healthcare, Inc., No. 1:16-cv-01352;
`
`• Eli Lilly & Co. v. Actavis Laboratories UT, Inc., No. 1:16-cv-01119;
`
`• Eli Lilly & Co. v. Alembic Pharmaceuticals Ltd., No. 1:16-cv-01120;
`
`• Eli Lilly & Co. v. Aurobindo Pharma Ltd., No. 1:16-cv-01121;
`
`• Eli Lilly & Co. v. Cipla Ltd., No. 1:16-cv-01208;
`
`• Eli Lilly & Co. v. Mylan Pharms. Inc., No. 1:16-cv-01122;
`
`• Eli Lilly & Co. v. Sun Pharm. Indus., Ltd., No. 2:16-cv-00518;
`
`2
`
`
`
`• Eli Lilly & Co. v. Teva Pharms. USA Inc., No. 2:16-cv-00519;
`
`• Eli Lilly & Co. v. Zydus Pharms. (USA) Inc., No. 2:16-cv-00520;
`
`These actions have been consolidated for pretrial proceedings under the lead
`
`case, Eli Lilly & Co. v. Actavis Laboratories UT, Inc., l:16-cv-01119-AJT-MSN.
`
`The district court issued a scheduling order and held a pretrial conference on
`
`December 7, 2016, and set a final pretrial conference for April 20, 2017, with trial
`
`within 4-8 weeks thereafter.
`
`Eli Lilly & Co. v. Apotex, Inc., No. 3:16-cv-00941, was filed on November
`
`30, 2016, in the United States District Court for the Eastern District of Virginia,
`
`seeking a judgment that the claims of U.S. Patent 6,943,166 are valid and
`
`infringed. This case was consolidated under the lead case, l:16-cv-01119-AJT-
`
`MSN, on January 11, 2017.
`
`MonoSol RX, LLC v. ICOS Corp., IPR2017-00412, was filed on December
`
`6, 2016, and corrected on December 7, 2016, before the Patent Trial and Appeal
`
`Board, seeking cancelation of Claims 1-12 of U.S. Patent 6,943,166.
`
`IntelGenX Corp. v. ICOS Corp., IPR2016-00678, was filed on February 2,
`
`2016, before the Patent Trial and Appeal Board, seeking cancelation of Claims 1-
`
`12 of U.S. Patent 6,943,166. Institution was denied on September 1, 2016. The
`
`proceeding was terminated by Order November 29, 2016.
`
`3
`
`
`
`Eli Lilly & Co. v. Ajanta Pharma, Ltd., No. 1:17-cv-00020, was filed on
`
`December 13, 2016, in the United States District Court for the Eastern District of
`
`Virginia, seeking a judgment that the claims of U.S. Patent 6,943,166 are valid and
`
`infringed. This case was consolidated under the lead case, l:16-cv-01119-AJT-
`
`MSN, on January 11, 2017.
`
`Patent Owner is unaware of any other related matters that would affect or be
`
`affected by this proceeding.
`
`C. Lead and Back-up Counsel
`
`In accordance with 37 C.F.R. § 42.8(b)(3), Patent Owner designates the
`
`following counsel to transact all business in the Patent Trial & Appeal Board of the
`
`United States Patent & Trademark Office in connection with the above-captioned
`
`Inter Partes Review. Patent Owner also consents to e-mail service at ICOS-
`
`IPRs@finnegan.com.
`
`Mark J. Feldstein (Lead Counsel)
`
`Phone: (202) 408-4092
`
`Finnegan, Henderson, Farabow,
`
`Fax: (202) 408-4400
`
` Garrett & Dunner, LLP
`
`mark.feldstein@finnegan.com
`
`901 New York Avenue, NW
`
`USPTO Reg. No. 46,693
`
`Washington, DC 20001-4413
`
`
`
`4
`
`
`
`Joshua L. Goldberg (First Back-Up Counsel)
`
`Phone: (202) 408-6092
`
`Finnegan, Henderson, Farabow,
`
`Fax: (202) 408-4400
`
` Garrett & Dunner, LLP
`
`joshua.goldberg@finnegan.com
`
`901 New York Avenue, NW
`
`USPTO Reg. No. 59,369
`
`Washington, DC 20001-4413
`
`
`
`Yieyie Yang (Back-Up Counsel)
`
`Phone: (202) 216-5170
`
`Finnegan, Henderson, Farabow,
`
`Fax: (202) 408-4400
`
` Garrett & Dunner, LLP
`
`yieyie.yang@finnegan.com
`
`901 New York Avenue, NW
`
`USPTO Reg. No. 71,923
`
`Washington, DC 20001-4413
`
`Maureen D. Queler (Back-Up Counsel)
`
`Phone: (202) 408-4294
`
`Finnegan, Henderson, Farabow,
`
`Fax: (202) 408-4400
`
` Garrett & Dunner, LLP
`
`maureen.queler@finnegan.com
`
`901 New York Avenue, NW
`
`USPTO Reg. No. 61,879
`
`Washington, DC 20001-4413
`
`
`
`Mark J. Stewart (Back-Up Counsel)
`
`Phone: (317) 276-0280
`
`Eli Lilly and Company
`
`Lilly Corporate Center
`
`Indianapolis, IN 46285
`
`Fax: (317) 276-3861
`
`stewart_mark@lilly.com
`
`USPTO Reg. No. 43,936
`
`5
`
`
`
`Dan L. Wood (Back-Up Counsel)
`
`Phone: (317) 277-3366
`
`Eli Lilly and Company
`
`Lilly Corporate Center
`
`Indianapolis, IN 46285
`
`Fax: (317) 276-3861
`
`wood_dan_l@lilly.com
`
`USPTO Reg. No. 48,613
`
`Gerald P. Keleher (Back-Up Counsel)
`
`Phone: (317) 276-3964
`
`Eli Lilly and Company
`
`Lilly Corporate Center
`
`Indianapolis, IN 46285
`
`Fax: (317) 276-0894
`
`keleher_gerald@lilly.com
`
`USPTO Reg. No. 43,707
`
`
`
`
`
`
`
`The undersigned counsel welcomes a telephone call should the Office have
`
`any requests or questions.
`
`
`
`
`
`
`
`
`
`
`
`Dated: January 11, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`/Mark J. Feldstein/
`Mark J. Feldstein (Lead Counsel,
` Reg. No. 46,693)
`Joshua L. Goldberg (First Back-up Counsel
` Reg. No. 59,369)
`Yieyie Yang (Back-up Counsel
` Reg. No. 71,923)
`Maureen D. Queler (Back-Up Counsel,
` Reg. No. 61,879)
`Mark J. Stewart (Back-up Counsel,
` Reg. No. 43,936)
`Dan L. Wood (Back-up Counsel,
` Reg. No. 48,613)
`Gerald P. Keleher (Back-Up Counsel,
` Reg. No. 43,707)
`
`6
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`Under 37 C.F.R. § 42.6(e), the undersigned certifies that PATENT
`
`OWNER’S UPDATED MANDATORY NOTICES was served by electronic
`
`mail on this 11th day of January, 2017, to counsel for Petitioner Mylan
`
`Pharmaceuticals Inc.:
`
`
`
`
`
`
`
`
`
`
`Steven W. Parmelee (sparmelee@wsgr.com)
`
`Michael T. Rosato (mrosato@wsgr.com)
`
`Jad A. Mills (jmills@wsgr.com)
`
`
`
`
`
`
`
`
`
`
`
`
`Date: January 11, 2017
`
`
`
`
`
`
`
`
`
`By: /John W. Kozikowski/
` John W. Kozikowski
` Litigation Legal Assistant
` Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP